Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
2160 On Other Exchanges
2160 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

gni group ltd (2160) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GNI GROUP LTD (2160)

Related News

No related news articles were found.

gni group ltd (2160) Related Businessweek News

No Related Businessweek News Found

gni group ltd (2160) Details

GNI Group Ltd., a bio-pharma company, engages in the research, development, manufacturing, and sale of pharmaceutical drugs and traditional Chinese medicines for the treatment of cancer and inflammatory diseases in Asia. It offers Etuary, a small molecule compound approved for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary for the treatment of radiation pneumonitis, which is in pilot study for Phase III clinical trials; diabetic nephropathy; and connective tissue disease associated interstitial lung disease. Its products also include Tamibarotene, a therapeutic agent for treating acute promyelocytic leukemia; F351, a small molecule compound in Phase II clinical trials for the treatment of liver fibrosis, and in preclinical stage for the treatment of chronic kidney failure; and F573, a di-peptide pan-caspase irreversible inhibitor for acute liver failure and acute-on-chronic liver failure. The company was founded in 2001 and is headquartered in Tokyo, Japan.

130 Employees
Last Reported Date: 03/27/15
Founded in 2001

gni group ltd (2160) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gni group ltd (2160) Key Developments

GNI Group Ltd. to Report Q2, 2015 Results on Aug 12, 2015

GNI Group Ltd. announced that they will report Q2, 2015 results on Aug 12, 2015

GNI Group Ltd. Presents at Macquarie Global Emerging Leaders Corporate Day - New York, Jun-15-2015

GNI Group Ltd. Presents at Macquarie Global Emerging Leaders Corporate Day - New York, Jun-15-2015 . Venue: Sofitel New York, 45 West 44th Street, New York, NY 10036, United States.

GNI Group Ltd. to Report Q1, 2015 Results on May 15, 2015

GNI Group Ltd. announced that they will report Q1, 2015 results on May 15, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2160:JP ¥214.00 JPY +6.00

2160 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2160.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2160 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 31.4x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GNI GROUP LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at